Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1,1,1,3,3,3-hexafluoro-2-(((5-fluoro-2-(1-(2-fluorobenzyl)-5-(isoxazol-3-yl)-1h-pyrazol-3-yl) Pyrimidin-4-yl)amino)methyl)propan-2-ol
2. Iw-1973
1. 1628730-49-3
2. Iw-1973
3. Praliciguat [inn]
4. R1s0h458sa
5. 1,1,1,3,3,3-hexafluoro-2-[[[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]amino]methyl]propan-2-ol
6. 2-propanol, 1,1,1,3,3,3-hexafluoro-2-(((5-fluoro-2-(1-((2-fluorophenyl)methyl)-5-(3-isoxazolyl)-1h-pyrazol-3-yl)-4-pyrimidinyl)amino)methyl)-
7. 2-propanol, 1,1,1,3,3,3-hexafluoro-2-[[[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(3-isoxazolyl)-1h-pyrazol-3-yl]-4-pyrimidinyl]amino]methyl]-
8. Praliciguatum
9. Praliciguat (usan/inn)
10. Praliciguat [usan]
11. Unii-r1s0h458sa
12. Praliciguat [who-dd]
13. Gtpl9900
14. Chembl4297214
15. Schembl16082414
16. Chebi:142431
17. Bdbm321618
18. Dtxsid901101232
19. Ex-a5960
20. Iw1973
21. Us10183021, Compound I-324
22. Bp177758
23. Hy-109039
24. Cs-0031480
25. D11274
26. D87220
27. 1,1,1,3,3,3-hexafluoro-2-(((5-fluoro-2-(1-((2-fluorophenyl)methyl)-5-(1,2-oxazol-3-yl)-1h-pyrazol-3-yl)pyrimidin-4-yl)amino)methyl)propan-2-ol
28. 1,1,1,3,3,3-hexafluoro-2-(((5-fluoro-2-(1-(2-fluorobenzyl)-5-(isoxazol-3-yl)-1h-pyrazol-3-yl) Pyrimidin-4-yl)amino)methyl)propan-2-ol
29. 1,1,1,3,3,3-hexafluoro-2-[({5-fluoro-2-[1-(2-fluorobenzyl)-5-(1,2-oxazol-3-yl)-1h-pyrazol-3-yl]pyrimidin-4-yl}amino)methyl]propan-2-ol
30. 1,1,1,3,3,3-hexafluoro-2-[[[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(3-isoxazolyl)-1h-pyrazol-3-yl]-4-pyrimidinyl]amino]methyl]-2-propanol
31. 1,1,1-trifluoro-3-[(5-fluoro-2-{1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)-1h-pyrazol-3-yl}pyrimidin-4-yl)amino]-2-(trifluoromethyl)propan-2-ol
| Molecular Weight | 534.4 g/mol |
|---|---|
| Molecular Formula | C21H14F8N6O2 |
| XLogP3 | 3.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 7 |
| Exact Mass | 534.10504901 g/mol |
| Monoisotopic Mass | 534.10504901 g/mol |
| Topological Polar Surface Area | 102 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 748 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Guanylyl Cyclase C Agonists
Compunds that bind to and activate GUANYLYL CYCLASE-C RECEPTORS. (See all compounds classified as Guanylyl Cyclase C Agonists.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
61
PharmaCompass offers a list of Praliciguat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Praliciguat manufacturer or Praliciguat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Praliciguat manufacturer or Praliciguat supplier.
PharmaCompass also assists you with knowing the Praliciguat API Price utilized in the formulation of products. Praliciguat API Price is not always fixed or binding as the Praliciguat Price is obtained through a variety of data sources. The Praliciguat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Praliciguat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Praliciguat, including repackagers and relabelers. The FDA regulates Praliciguat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Praliciguat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Praliciguat supplier is an individual or a company that provides Praliciguat active pharmaceutical ingredient (API) or Praliciguat finished formulations upon request. The Praliciguat suppliers may include Praliciguat API manufacturers, exporters, distributors and traders.
Praliciguat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Praliciguat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Praliciguat GMP manufacturer or Praliciguat GMP API supplier for your needs.
A Praliciguat CoA (Certificate of Analysis) is a formal document that attests to Praliciguat's compliance with Praliciguat specifications and serves as a tool for batch-level quality control.
Praliciguat CoA mostly includes findings from lab analyses of a specific batch. For each Praliciguat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Praliciguat may be tested according to a variety of international standards, such as European Pharmacopoeia (Praliciguat EP), Praliciguat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Praliciguat USP).
